公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1994 | Bivariate flow karyotyping, sorting, and peak assignment of all rat chromosomes | Shepel L.A.; Morrissey L.W.; LIH-CHING HSU ; Gould M.N. | Genomics | 21 | 20 | |
1998 | BRCA1 is associated with the centrosome during mitosis | LIH-CHING HSU ; White R.L. | Proceedings of the National Academy of Sciences of the United States of America | 274 | 271 | |
2020 | The (+)-brevipolide H displays anticancer activity against human castration-resistant prostate cancer: The role of oxidative stress and Akt/mTOR/p70S6K dependent pathways in G1 checkpoint arrest and apoptosis | Sheng Y.-H.; Leu W.-J.; Chen C.-N.; Hsu J.-L.; Liu Y.-T.; LIH-CHING HSU ; Hou D.-R.; JIH-HWA GUH | Molecules | 4 | 4 | |
2024 | Cardenolide glycosides sensitize gefitinib-induced apoptosis in non-small cell lung cancer: inhibition of Na+/K+-ATPase serving as a switch-on mechanism | Du, Chi-Min; Leu, Wohn-Jenn; Jiang, Yi-Huei; Chan, She-Hung; Chen, Ih-Sheng; Chang, Hsun-Shuo; LIH-CHING HSU ; Hsu, Jui-Ling; JIH-HWA GUH | Naunyn-Schmiedeberg's archives of pharmacology | | | |
2005 | Centrosome abnormalities in ovarian cancer | LIH-CHING HSU ; Kapali M.; DeLoia J.A.; Gallion H.H. | International Journal of Cancer | 44 | 42 | |
2020 | Chalcones Display Anti-NLRP3 Inflammasome Activity in Macrophages through Inhibition of Both Priming and Activation Steps-Structure-Activity-Relationship and Mechanism Studies | Leu W.-J.; Chu J.-C.; Hsu J.-L.; Du C.-M.; Jiang Y.-H.; LIH-CHING HSU ; Huang W.-J.; JIH-HWA GUH | Molecules (Basel, Switzerland) | 8 | 8 | |
2021 | Characterization of a fluorescent glucose derivative 1-NBDG and its application in the identification of natural SGLT1/2 inhibitors | Kao, Ting-Yu; Wu, Hwa-Wei; SHOEI-SHENG LEE ; PI-HUI LIANG ; JIH-HWA GUH ; LIH-CHING HSU | Journal of food and drug analysis | 3 | 2 | |
1993 | Cloning and Characterization of Overexpressed Genes in the Mammary Gland of Rat Strains Carrying the Mammary CarcinomaSuppressor (Mcs) Gene | LIH-CHING HSU ; Gould M.N. | Cancer Research | 13 | 13 | |
2022 | The Combination of a Novel GLUT1 Inhibitor and Cisplatin Synergistically Inhibits Breast Cancer Cell Growth By Enhancing the DNA Damaging Effect and Modulating the Akt/mTOR and MAPK Signaling Pathways | Weng, Hao-Cheng; Sung, Chieh-Ju; Hsu, Jui-Ling; Leu, Wohn-Jenn; JIH-HWA GUH ; FAN-LU KUNG ; LIH-CHING HSU | Frontiers in pharmacology | 9 | 6 | |
2019 | The combination of MK-2206 and WZB117 exerts a synergistic cytotoxic effect against breast cancer cells | Li Y.-L.; Weng H.-C.; Hsu J.-L.; SHU-WHA LIN ; JIH-HWA GUH ; LIH-CHING HSU | Frontiers in Pharmacology | 24 | 22 | |
2007 | Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: Implications for pathogenesis of ovarian cancer | Wilcox C.B.; Feddes G.O.; Willett-Brozick J.E.; LIH-CHING HSU ; DeLoia J.A.; Baysal B.E. | BMC Cancer | 41 | 40 | |
2023 | Design, Synthesis, and Evaluation of Glucose Transporter Inhibitor-SN38 Conjugates for Targeting Colorectal Cancer | Chiu, Pei Fang; Chang, Chun Kai; Huang, Pin Shuo; Lin, You Yu; Lin, Chung Shun; Yang, Hui Yi; LIH-CHING HSU ; LINDA CHIA-HUI YU ; PI-HUI LIANG | Journal of Medicinal Chemistry | 2 | 0 | |
2013 | Development of a novel non-radioactive cell-based method for the screening of SGLT1 and SGLT2 inhibitors using 1-NBDG | Chang, Hung-Chi; Yang, Su-Fu; Huang, Ching-Chun; Lin, Tzung-Sheng; PI-HUI LIANG ; CHUN-JUNG LIN ; LIH-CHING HSU | Molecular BioSystems | 17 | 16 | |
2012 | Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor | LIH-CHING HSU ; Durrant D.E.; Huang C.-C.; Chi N.-W.; Baruchello R.; Rondanin R.; Rullo C.; Marchetti P.; Grisolia G.; Simoni D.; Lee R.M. | Investigational New Drugs | 14 | 10 | |
2019 | Dihydroartemisinin–Bile Acid Hybridization as an Effective Approach to Enhance Dihydroartemisinin Anticancer Activity | Marchesi E.; Chinaglia N.; Capobianco M.L.; Marchetti P.; Huang T.-E.; Weng H.-C.; JIH-HWA GUH ; LIH-CHING HSU ; Perrone D.; Navacchia M.L. | ChemMedChem | 17 | 17 | |
2022 | Discovery of New Glucose Uptake Inhibitors as Potential Anticancer Agents by Non-Radioactive Cell-Based Assays | Hung, Hsueh-Chih; Li, Li-Cheng; JIH-HWA GUH ; FAN-LU KUNG ; LIH-CHING HSU | Molecules (Basel, Switzerland) | 3 | 1 | |
2020 | Discovery of novel agents on spindle assembly checkpoint to sensitize vinorelbine-induced mitotic cell death against human non-small cell lung cancers | Chang Y.-C.; Tseng Y.-L.; Leu W.-J.; Du C.-M.; Jiang Y.-H.; LIH-CHING HSU ; Hsu J.-L.; Hou D.-R.; JIH-HWA GUH | International Journal of Molecular Sciences | 2 | 1 | |
2016 | Downregulation of COMMD1 by MIR-205 promotes a positive feedback loop for amplifying inflammatory- and stemness-associated properties of cancer cells | Yeh D.-W.; Chen Y.-S.; Lai C.-Y.; Liu Y.-L.; Lu C.-H.; Lo J.-F.; Chen L.; LIH-CHING HSU ; Luo Y.; Xiang R.; Chuang T.-H. | Cell Death and Differentiation | 34 | 34 | |
2024 | Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway | Hsu, Jui-Ling; Leu, Wohn-Jenn; LIH-CHING HSU ; Hsieh, Chia-Hsun; JIH-HWA GUH | Oncology letters | | | |
2015 | Effects of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at the blood-brain barrier and its implications to the transport of neurotoxins | Wu, Kuo-Chen; Lu, Ya-Hsuan; Peng, Yi-Hsuan; LIH-CHING HSU ; CHUN-JUNG LIN | Journal of Neurochemistry | 23 | 15 | |